(Total Views: 601)
Posted On: 05/13/2021 12:42:47 AM
Post# of 149028
Leronlimab binds to the N terminus and the second extracellular loop so where's the problem?
With narsoplimab it blocks the complement activation pathway that can induce a cytokine storm but leaves the classical (much stronger) and alternative pathway for the cytokine storm to develop. Leronlimab blocking the chemokines takes care of all three pathways.
With narsoplimab it blocks the complement activation pathway that can induce a cytokine storm but leaves the classical (much stronger) and alternative pathway for the cytokine storm to develop. Leronlimab blocking the chemokines takes care of all three pathways.
(13)
(0)Scroll down for more posts ▼
